Location History:
- Kronberg, DE (2007)
- Frankfurt-am-Main, DE (2013 - 2020)
Company Filing History:
Years Active: 2007-2020
Title: The Innovations of Harald Berchtold
Introduction
Harald Berchtold is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of insulin formulations. With a total of 10 patents to his name, Berchtold's work has had a substantial impact on diabetes treatment.
Latest Patents
Among his latest patents are "Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives," which disclose innovative methods for improving the stability of insulin products. Another significant patent is for "Stabilized pharmaceutical formulations of insulin aspart," which also focuses on enhancing the stability of this specific insulin formulation. These patents reflect Berchtold's commitment to advancing medical science and improving patient care.
Career Highlights
Throughout his career, Berchtold has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis Deutschland GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, leading to the successful patenting of his formulations.
Collaborations
Berchtold has collaborated with several professionals in his field, including Oliver Bley and Petra Loos. These partnerships have contributed to the successful development of his patented formulations and have fostered a collaborative environment for innovation.
Conclusion
Harald Berchtold's contributions to the pharmaceutical industry, particularly in insulin formulation, demonstrate his dedication to innovation and improving healthcare outcomes. His patents and collaborations highlight the importance of teamwork in advancing medical science.